Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 07:53 PM EDT

Passage Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
57.63M 63.36M 37.57M 32.29M 24.77M 36.77M 21.71M 33.58M 30.29M 33.37M 34.6M 62.57M 91.13M 101.61M 128.97M 162.89M 215.46M 249.52M
Short-Term Investments
n/a n/a 39.18M 52.53M 67M 67.75M 92.58M 99.2M 121.19M 134.4M 155.01M 151.19M 148.12M 165.48M 186.81M 191.51M 192.34M 188.07M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
270K 274K 463K 463K 516K 662K 433K 433K 433K 433K 4.27M 4.72M 5.22M 5.72M 6.2M 6.71M 7.21M 7.65M
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.69M 2.12M 838K 1.21M 1.83M 1.98M 2.74M 1.28M 1.23M 1.69M 926K 1.51M 2.32M 2.83M 1.73M 3.13M 3.86M 9.99M
Total Current Assets
60.31M 66.67M 78.81M 87.22M 95M 108.29M 117.96M 135.71M 153.63M 171.62M 197.04M 222.52M 250.58M 283M 325.07M 366.47M 418.84M 450.95M
Property-Plant & Equipment
18.61M 19.06M 23.13M 24.07M 29.88M 31.58M 32.15M 33.11M 39.64M 41.19M 42.24M 42.81M 43.62M 44.5M 23.81M 17.77M 13.48M 6.57M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
18.88M 19.34M 23.6M 24.54M 30.39M 32.24M 32.59M 33.55M 40.07M 41.62M 46.51M 47.53M 48.84M 50.22M 30.01M 24.47M 20.69M 14.22M
Total Assets
79.2M 86.01M 102.41M 111.75M 125.39M 140.53M 150.54M 169.26M 193.7M 213.24M 243.55M 270.05M 299.42M 333.22M 355.08M 390.94M 439.52M 465.17M
Account Payables
2.4M 1.46M 742K 1.49M 621K 1.69M 1.3M 2.75M 3.38M 3.03M 4.07M 4.51M 8.21M 9.13M 9.45M 8.98M 16.4M 6.25M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
3.59M n/a n/a n/a n/a 3.67M 3.37M 3.35M 3.33M 3.3M n/a 3.25M 3.23M 3.12M n/a n/a n/a n/a
Other Current Liabilities
11.32M 10.3M 12.63M 8.96M 6.11M -3.67M 5.26M 4.13M 4.05M 4.23M 85K 3.75M 6.65M 7.24M 661K 626K 2.26M 2M
Total Current Liabilities
19.8M 17.82M 19.36M 16.95M 12.38M 12.84M 16.34M 19.81M 19.87M 17.24M 18.35M 21.62M 27.13M 27.48M 29.5M 22.25M 31.25M 19.47M
Long-Term Debt
21.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a 2M n/a n/a n/a n/a 6.92M 6.46M 6.01M 4.2M
Total Long-Term Liabilities
21.14M 21.48M 21.79M 22.09M 22.45M 22.81M 22.92M 23.17M 23.41M 25.65M 23.83M 24.04M 24.24M 24.43M 6.92M 6.46M 6.01M 4.2M
Total Liabilities
40.94M 39.3M 41.15M 39.04M 34.84M 35.65M 39.26M 42.98M 43.28M 42.89M 42.18M 45.66M 51.37M 51.91M 36.42M 28.71M 37.26M 23.67M
Total Debt
24.73M 25.12M 25.48M 25.82M 26.15M 26.48M 26.29M 26.52M 26.74M 26.95M 27.11M 27.29M 27.47M 27.55M n/a n/a n/a n/a
Common Stock
n/a 6K 6K 6K 6K 6K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K
Retained Earnings
-684.02M -674.64M -659.24M -646.51M -627.17M -611.18M -594.47M -577.71M -550.6M -526.74M -492.41M -465.33M -438.63M -399.09M -356.28M -305.13M -258.21M -209.78M
Comprehensive Income
n/a n/a 8K 32K -67K -69K -43K -192K -340K -427K -966K -1.47M -1.58M -1.33M -413K 33K 19K -7K
Shareholders Equity
38.26M 46.71M 61.26M 72.72M 90.56M 104.88M 111.28M 126.28M 150.41M 170.35M 201.37M 224.4M 248.05M 281.31M 318.66M 362.23M 402.27M 441.5M
Total Investments
n/a n/a 39.18M 52.53M 67M 67.75M 92.58M 99.2M 121.19M 134.4M 155.01M 151.19M 148.12M 165.48M 186.81M 191.51M 192.34M 188.07M